Real-World Effectiveness of Nirsevimab Against RSV-Related and All-Cause Respiratory Tract Infections in Chinese Infants
Clinical trial NCT07382219 · COMPLETED
Trial details
- NCT number
- NCT07382219
- Sponsor
- Han Tongyan
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-01
- Primary completion
- 2025-10-31
- Enrollment
- 816
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.